Skip to main content

Table 1 Basic information of the studies involved in the meta-analysis

From: Effectiveness of tranexamic acid in reducing blood loss in spinal surgery: a meta-analysis

Studies

Number of pts (TXA/P)

Sex

Age

Weight

Male (TXA/P)

Female (TXA/P)

TXA

Placebo

TXA

Placebo

Neilipovitz DT, 2001 [15]

22/18

17 (12/5)

23 (10/13)

14.1 ± 2.1

13.7 ± 2.5

41.8 ± 16.7

50.6 ± 20.2

Sethna NF, 2005 [16]

23/21

30 (17/13)

14 (6/8)

13.6 ± 1.8

14.0 ± 2.0

59.4 ± 18.3

52.4 ± 15.7

Wong J, 2008 [17]

73/74

47 (21/26)

100 (52/48)

56.8 ± 16.2

50.0 ± 16.2

72.9 ± 17.2

73.9 ± 16.1

Elwatidy S, 2008 [19]

32/32

39 (21/18)

25 (11/14)

51.56 ± 19.08

49.75 ± 21.04

72.48 ± 13.81

69.63 ± 17.29

Farrokhi MR, 2011 [18]

38/38

18 (11/7)

58 (27/31)

45.5 ± 11.6

51.4 ± 11.6

66.6 ± 9.9

66.9 ± 9.4

Tsutsumimoto T, 2011 [20]

20/20

31 (16/15)

9 (4/5)

68.0 ± 11.0

65.8 ± 11.8

59.6 ± 8.3

61.3 ± 10.2

  1. Pts, patients; TXA/P, tranexamic acid group/placebo group.